High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.
S
S
Jolles
D001327:Autoimmune Diseases / Q000628:therapy*; D016107:Epidermolysis Bullosa Acquisita / Q000628:therapy; D005260:Female; D006801:Humans; D007070:Immunoglobulin A; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D010390:Pemphigoid, Benign Mucous Membrane / Q000628:therapy; D010391:Pemphigoid, Bullous / Q000628:therapy; D010392:Pemphigus / Q000628:therapy; D012872:Skin Diseases, Vesiculobullous / Q000628:therapy*
D007070:Immunoglobulin A; D016756:Immunoglobulins, Intravenous